![Erik Berglund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Erik Berglund formerly worked at Gilead Sciences, Inc., as Senior Director-Regulatory Affairs and Vistagen Therapeutics, Inc., as Senior Vice President-Global Regulatory Affairs from 2021 to 2025.
Dr. Berglund received his doctorate degree from Umea Universitet.
Former positions of Erik Berglund
| Companies | Position | End |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | General Counsel | 10/01/2025 |
| GILEAD SCIENCES, INC. | General Counsel | - |
Training of Erik Berglund
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
- Stock Market
- Insiders
- Erik Berglund
